Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Jul-Aug;6(4):322-30.
doi: 10.6004/jadpro.2015.6.4.3. Epub 2015 Jul 1.

Hormone Replacement Therapy: An Increased Risk of Recurrence and Mortality for Breast Cancer Patients?

Molly Lupo  1 , Joyce E Dains  1 , Lydia T Madsen  1
Affiliations
Review

Hormone Replacement Therapy: An Increased Risk of Recurrence and Mortality for Breast Cancer Patients?

Molly Lupo et al. J Adv Pract Oncol. 2015 Jul-Aug.

Abstract

Historically, randomized controlled trials (RCTs) have shown an increased risk of recurrence and mortality among women who have used primarily oral HRT after breast cancer. However, many of these studies have had design flaws that may impact the findings. Numerous investigators have concluded that additional RCTs should be performed, but because of ethical issues and logistic challenges, large-scale RCTs are unlikely. Thus, the authors conducted an integrative review investigating recurrence and mortality data among breast cancer survivors who have used hormone replacement therapy (HRT). They recommend a stepwise algorithm for treating vaginal symptoms in breast cancer survivors: (1) start with nonhormonal treatments; (2) progress to a detailed discussion among patients and health-care professionals about the current known risks and benefits of vaginal estrogen; and (3) conclude with mutual decision-making between health-care providers and patients regarding the use of vaginal estrogen treatment.

PubMed Disclaimer

Figures

Table 1
Table 1
Recurrence and Mortality Dataa
Table 2
Table 2
Hormone Replacement Therapy Delivery Route
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Beckmann M. W., Jap D., Djahansouzi S., Nestle-Krämling C., Kuschel B., Dall P., Brumm C., Bender H. G. Hormone replacement therapy after treatment of breast cancer: effects on postmenopausal symptoms, bone mineral density and recurrence rates. Oncology. 2001;60:199–206. - PubMed
    1. Brewster Abenaa M., Do Kim-Anh, Thompson Patricia A., Hahn Karin M., Sahin Aysegul A., Cao Yumei, Stewart Maureen M., Murray James L., Hortobagyi Gabriel N., Bondy Melissa L. Relationship between epidemiologic risk factors and breast cancer recurrence. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2007;25:4438–4444. - PMC - PubMed
    1. Casper R. F, Barbieri R. L., Crowley W. F, Martin K. A. Clinical manifestations and diagnosis of menopause. 2015 Retrieved from Retrieved from http://www.uptodate.com/contents/clinical-manifestations-....
    1. Col Nananda F., Kim Jung A., Chlebowski Rowan T. Menopausal hormone therapy after breast cancer: a meta-analysis and critical appraisal of the evidence. Breast cancer research : BCR. 2005;7:R535–540. - PMC - PubMed
    1. Decker D. A., Pettinga J. E., VanderVelde N., Huang R. R., Kestin L., Burdakin J. H. Estrogen replacement therapy in breast cancer survivors: A matched-controlled series. Menopause. 2003;10:277–285. - PubMed

LinkOut - more resources